Literature DB >> 1301382

The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells.

C A Kelton1, S V Cheng, N P Nugent, R L Schweickhardt, J L Rosenthal, S A Overton, G D Wands, J B Kuzeja, C A Luchette, S C Chappel.   

Abstract

Follicle stimulating hormone (FSH) receptor clones were isolated from a human testis cDNA library. Characterization of the cDNA clones showed that the DNA and predicted amino acid sequences of the long open reading frame differed from a previously published human ovarian FSH receptor sequence (Minegish et al. (1991) Biochem. Biophys. Res. Commun. 175, 1125-1130) by seven nucleotides and five amino acids. A human FSH receptor splice variant was also identified and characterized. A full-length human FSH receptor cDNA was engineered for expression in COS-7, CHO, and Y-1 cells. In transient transfections of COS-7 cells and stable transfections of Y-1 cells, efficient FSH receptor mRNA accumulation and isolation of FSH-responsive cell lines occurred only when an intron was included in the 5' untranslated region of the FSH receptor transcription unit. Y-1 cells stably transfected with the FSH receptor responded to FSH treatment by rounding up and by synthesizing increased amounts of progesterone. Stably transfected CHO cell lines, which responded to FSH by synthesizing increased amounts of cAMP, were isolated irrespective of the presence of the heterologous intron. The FSH-responsive CHO and Y-1 cell lines may be suitable for the development of better in vitro FSH bioassays. These cells also constitute a convenient source of human FSH receptor protein for use in radioreceptor assays and in studies of receptor-ligand interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301382     DOI: 10.1016/0303-7207(92)90220-z

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

Review 1.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Decreased degradation of internalized follicle-stimulating hormone caused by mutation of aspartic acid 6.30(550) in a protein kinase-CK2 consensus sequence in the third intracellular loop of human follicle-stimulating hormone receptor.

Authors:  Kerri S Kluetzman; Richard M Thomas; Cheryl A Nechamen; James A Dias
Journal:  Biol Reprod       Date:  2011-01-26       Impact factor: 4.285

3.  The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization.

Authors:  Richard M Thomas; Cheryl A Nechamen; Joseph E Mazurkiewicz; Alfredo Ulloa-Aguirre; James A Dias
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

4.  Ectopic expression of FSH receptor isoforms in neoplastic but not in endothelial cells from pancreatic neuroendocrine tumors.

Authors:  C Sardella; D Russo; F Raggi; M Lombardi; C Urbani; S Brogioni; U Boggi; N Funel; B Chifenti; D Campani; G Fanelli; P Marchetti; F Basolo; M T Locci; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2012-06-25       Impact factor: 4.256

5.  Follicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSH.

Authors:  Cengiz Karakaya; Ozlem Guzeloglu-Kayisli; Rebecca J Hobbs; Tsilya Gerasimova; Asli Uyar; Mehmet Erdem; Mesut Oktem; Ahmet Erdem; Seyhan Gumuslu; Deniz Ercan; Denny Sakkas; Pierre Comizzoli; Emre Seli; Maria D Lalioti
Journal:  Mol Hum Reprod       Date:  2014-03-25       Impact factor: 4.025

6.  Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys.

Authors:  Teresa Zariñán; Marco A Perez-Solís; Guadalupe Maya-Núñez; Patricia Casas-González; P Michael Conn; James A Dias; Alfredo Ulloa-Aguirre
Journal:  Mol Cell Endocrinol       Date:  2010-03-04       Impact factor: 4.102

7.  A follicle-stimulating hormone receptor ecto-domain epitope that is a target for receptor immunoneutralization yet does not affect ligand contact and activation.

Authors:  X Liu; G M Butterstein; B Lindau-Shepard; H A Brumberg; J A Dia
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

8.  Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(-/-) FORKO mice.

Authors:  M Ghadami; E El-Demerdash; S A Salama; A A Binhazim; A E Archibong; X Chen; B R Ballard; M R Sairam; A Al-Hendy
Journal:  Mol Hum Reprod       Date:  2010-01-19       Impact factor: 4.025

9.  Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH.

Authors:  Tsilya Gerasimova; Maria N Thanasoula; Dimitrios Zattas; Emre Seli; Denny Sakkas; Maria D Lalioti
Journal:  J Clin Endocrinol Metab       Date:  2010-01-08       Impact factor: 5.958

Review 10.  The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models.

Authors:  Eric T Siegel; Hyung-Goo Kim; Hiromi Koso Nishimoto; Lawrence C Layman
Journal:  Reprod Sci       Date:  2012-11-26       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.